Lim Bryant David 4
4 · Prelude Therapeutics Inc · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Lim Bryant David
CLO, CFO, Corp Sec.
Transactions
- Award
Employee Stock Option (right to buy)
2025-02-04+200,000→ 200,000 totalExercise: $1.11Exp: 2035-02-04→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on Feb 4, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.